Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
.1295 here we go $$$
New hod coming just have to be patience for big money.
YUP! Most likely Lisa knows the data is good.
.1178 It looks like we are gearing up for a new hod within the next 40 min.
I agree. This will be a significant victory for all of us. Often, we get caught up in wanting everything to happen immediately, but that's not the case here. Building a successful and profitable business takes time. We just need to patiently wait out this process.
YUP! We all going to be happy here. People will gradually come to understand the game being played here. It's an easy bet, with the odds favoring the shareholders. First, we don't have to worry about the grant extension until August 13, 2024. Second, we don't have to fret over the reverse split because the company isn't implementing one at this time. Third, we know Lisa is holding off on the reverse split because she knows what it takes to push us above the one-dollar mark. Heck, this is such an easy bet that soon everyone will want to ride on this boat.
Lisa is playing it safe and smart. She's holding both ace cards: one is the results of the data, and the other is the approval of the reverse split (r/s), just in case she can't move the share price above the one-dollar mark. We all know the answer. Positive Phase 3 data will quickly propel the share price above one dollar. This makes it an easy call to bet among the house. It's virtually a win-win situation for Lisa and the stakeholders.
Currently, they're not executing the reverse split (r/s) to elevate the price to the one-dollar mark. So, the question we ought to consider is: what will it take to surpass the one-dollar threshold? I suppose we all know the answer. Positive Phase 3 data will swiftly propel the share price above one dollar.
People are feeling apprehensive because the reverse split (RS) has been approved. However, it's not about the approval; it's about when they decide to implement it. Right now, they're not putting it into action, so let's just enjoy the ride.
I'm not complaining because my timing for buying and selling is excellent. I already had a substantial number of free shares, and now I've added more in anticipation of the Phase 3 data results.
No reverse split (R/S). I'm confident that the stock will continue to rise from here until they announce the data.
It sounds like she will announce the data soon...Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrhea.
I just added 8 thousand dollars because of no r/s for now.
04/09/24 05:13 PM ET Buy 33800 JAGX Executed @ $0.0983
04/09/24 05:04 PM ET Buy 17032 JAGX Executed @ $0.0992
04/09/24 05:04 PM ET Buy 162 JAGX Executed @ $0.0992
04/09/24 05:01 PM ET Buy 20000 JAGX Executed @ $0.0992
04/09/24 05:01 PM ET Buy 1200 JAGX Executed @ $0.0992
04/09/24 05:01 PM ET Buy 1927 JAGX Executed @ $0.0992
04/09/24 05:00 PM ET Buy 500 JAGX Executed @ $0.099199
04/09/24 05:00 PM ET Buy 100 JAGX Executed @ $0.0992
04/09/24 05:00 PM ET Buy 200 JAGX Executed @ $0.0992
04/09/24 05:00 PM ET Buy 300 JAGX Executed @ $0.0992
04/09/24 05:00 PM ET Buy 7900 JAGX Executed @ $0.0992
OT: I trade heavily every day. Bank on KULR, KZIA, and loaded up on IVP, FCEL, and FFIE today.
$IVP loading zone..!
Yes, and I think it will get the approval.
.049 Fully loaded. The offerings are over. Market Cap Market Cap $233,116 Supper undervalued here.
233,116 04/08/2024 Outstanding Shares 5,013,240 tiny O/S she can fly.
Strong day, somebody knows something after the vote. Can she break .10 and hold higher?
I've been steadily accumulating shares priced below $1.20. It's a fantastic bargain entry point.
Accumulating and now I am fully loaded under one dollar.
Truly simply a matter of time. Accumulation of .0015 will be greatly rewarded. TICK TOCK!
Good morning and happy birthday! When the MM drops the PPS on low volume, it technically doesn't affect much. With higher volume, we could easily see a jump to $0.003. Currently, it trades based on its merit. I no longer recommend people to come here, because, at the end of the day, they will flip away on our token. Additionally, whether the PPS is low or high, if we achieve the exchange to KOAN shares at a 1-1 rate, the current trading price won't matter. What matters is when the announcement comes, it will be too late for those wanting to get in at this dirt-cheap level for the exchange to KOAN shares.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174185980
Yup! I bought shares, accumulating them in the low $0.15 range, took the profit, and now I'm free-riding to dollar land.
Consolidation, next station is Dollar Land.
.40 breakout that is sweet $$
We are in the same situation as the insider who held the preferred shares. The Class A Preferred Shares have no dividend or conversion rights; they are created for vote control. Therefore, Class A will be terminated. Class B Convertible Preferred Stock has no voting rights, with a conversion rate of 20/1. During the quarter ended December 31, 2022, 4,500,000 shares of Series B Convertible Preferred Stock were redeemed for 70,000,000 shares of the Company’s Common Stock. Class C is where we need to be concerned, and the insiders have already converted them into common shares. This indicates they hold the common stock, which will later convert back into the preferred shares restricted for one year. Series F was terminated; therefore, right now, technically, everyone is holding the common shares and waiting to exchange them for KOAN shares.
Certainly. It's only a matter of time before they officially announce the share exchange with KOAN. Countless individuals will wake up one day regretting not having acquired shares for the exchange. Bookmark this post.
The key question that needs addressing is the fate of the EMGE common shareholders.
When we refer to “EMGE Equity Interests”, it refers to the transfer of ownership in EMGE. The ownership or financial stake in a company.
These are the common financial terms. Equity interest, interest, compound interest, liability interest...“EMGE Equity Interests” include both preferred and common shares. Furthermore, (EMGE Equity Interests) include common stock, preferred stock, bonds, warrants, and other financial instruments.
The management must offer greater transparency regarding the business action plan. Their failure to launch the business and address the issue, or outline their strategy moving forward, is a major concern. This lack of transparency is not helpful in increasing value for the stakeholders.
Pay attention to the statement I highlight in the quote below. This is a legal agreement that governs the exchange process. Equal number of issued and outstanding shares of preferred stock": This indicates that each EMGE Preferred Shareholder will exchange their EMGE Equity Interests for an equivalent number of preferred shares in the Company. Think about that for a moment. EMGE Preferred Shareholder exchange EQUIVALENT therefore, the EMGE common shares should be exchanged equal in value 1-1 as well. Imho.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174185980
But then it will be too late!...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174185980
That's an excellent question. Speaking from my own perspective and experiences with reverse triangular mergers, one example I can recall is PMPG. They utilized a 251G process in Delaware to absolve previous debts during their merger with HVMC. PMPG emerged as the surviving entity in this triangular merger, with shares issued at a 1:1 ratio.
The recent increase in authorized shares from 200 million to 2 billion for KOAN suggests that they are preparing for a common share exchange. Additionally, we are nearing the completion of the 251G process. KOAN, as a shell company, has no revenue and tangible assets, making it challenging to assign a definitive value to its shares. Despite this, it currently trades at around $0.04 per share. On the other hand, EMGE, trading at $0.002 per share, boasts tangible assets and revenue. Therefore, a 1:1 exchange ratio similar to the HVMC case could make sense from a management perspective. Such an exchange would offer long-term shareholders the opportunity to acquire EMGE shares at a price equivalent to $0.04 per share, potentially adding GREAT value to their investments.
YUP! Flippers and the FAKE LONG are clueless, they don't understand and see the true value here.
.15's to .83 can she hit dollar land?
JIM MORRISON OWNS 94.79% of the voting power of the Company’s outstanding voting securities.
After the completion of the 251(g) process, EMGE will undergo an exchange for KOAN shares. I eagerly await news akin to the VVPR merger share exchange. The announcement today regarding VVPR share exchange sparked a +400% surge in share price. EMGE, characterized by its low float and absence of dilution, presents the potential for us to emulate such a scenario with our own low-float stock.
You may want to reassess the company once more. The outstanding shares have remained unchanged for the past 10 months, and now Zimbler no longer holds the controlling vote.
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/
$EMGE TRIANGULAR MERGER DUE DILIGENCE UPDATE.
$EMGE On March 7, 2024, Resonate Blends, now known as KOAN, issued an 8-K entry into a Material Definitive Agreement, marking the execution of the triangular merger. KOAN, rebranded as Apollo, serves as the main parent company. Trading of KOAN and EMGE common shares will proceed as usual until the completion of the 251(g) reorganization of the new entity, Apollo. Following the conclusion of the 251(g) process, EMGE common shares will be exchanged for KOAN shares, and the company, now under parent company APOLLO, will undergo a name change through an official amendment to its name.
What makes this merger exceptional is NO reverse splits, the elimination of debts, and insider shares locked up for one year. On top of that, EMGE current float is under 300m. Remarkably, the share structure has remained unchanged since May 2023 marking ten months without dilution. Such stability is super rare in the realm of OTC land.
Let's now closely examine the subsidiaries of APOLLO BioWellness.
1 - EVOLUTIONARY BIOLOGICSIS Must see beautiful site: <><><> https://evolutionarybiologics.com/
In my humble opinion, it's evident that Morrison has all his ducks in a row, and it's only a matter of time before he launches a massive news campaign. Here's the proof: On September 12, 2023, (NASDAQ: BRTX) entered into a supply agreement with Evolutionary Biologics.
https://www.globenewswire.com/en/news-release/2023/09/12/2741711/0/en/BioRestorative-Therapies-Enters-into-Supply-Agreement-with-Evolutionary-Biologics.html
Additionally, he has the Cinema ads campaign ready for marketing Biologics products once the 251(g) process is completed. He organizes everything year in advance. His commitment to investing in product development and the Cinema ads campaign without diluting shares demonstrates his dedication to his companies and the shareholders. Such situations are beyond rare on the OTC land.
Watch the CINEMA ads Campaigns. Compelling and Essential Viewing: A Must-Watch Experience
https://apollobiowellness.com/on-demand-content/